APA (7th ed.) Citation

MÁ, G., M, Á., A, d. B., M, B., M, R., EF, V., & S, C. (2026). Targeted small molecules in polymyalgia rheumatica: The emerging role of JAK inhibitors beyond glucocorticoids and DMARDs. Expert opinion on pharmacotherapy, 27(7), 611. https://doi.org/10.1080/14656566.2026.2668585

Chicago Style (17th ed.) Citation

MÁ, González-Gay, Álvarez-Rubio M, de Benito-Vernière A, Belhaj-Gandar M, Roca-Magnet M, Vicente-Rabaneda EF, and Castañeda S. "Targeted Small Molecules in Polymyalgia Rheumatica: The Emerging Role of JAK Inhibitors Beyond Glucocorticoids and DMARDs." Expert Opinion on Pharmacotherapy 27, no. 7 (2026): 611. https://doi.org/10.1080/14656566.2026.2668585.

MLA (9th ed.) Citation

MÁ, González-Gay, et al. "Targeted Small Molecules in Polymyalgia Rheumatica: The Emerging Role of JAK Inhibitors Beyond Glucocorticoids and DMARDs." Expert Opinion on Pharmacotherapy, vol. 27, no. 7, 2026, p. 611, https://doi.org/10.1080/14656566.2026.2668585.